Clinical advances in pediatric nonalcoholic fatty liver disease - PubMed (original) (raw)

Review

. 2016 May;63(5):1718-25.

doi: 10.1002/hep.28441. Epub 2016 Mar 4.

Affiliations

Review

Clinical advances in pediatric nonalcoholic fatty liver disease

Jeffrey B Schwimmer. Hepatology. 2016 May.

No abstract available

PubMed Disclaimer

References

    1. Diseases NIoDaDaK. Non-Alcoholic Steatohepatitis 1998. Available from: http://archives.niddk.nih.gov/conf1999/displaypage.aspx?pagename=conf199....
    1. Schwimmer JB, Dunn W, Norman GJ, Pardee PE, Middleton MS, Kerkar N, et al. SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterology. 2010;138(4):1357–64. 64 e1–2. - PMC - PubMed
    1. Park J, Kim S, Park M. Alanine aminotransferase and metabolic syndrome in adolescents: the Korean National Health and Nutrition Examination Survey Study. Pediatric obesity. 2014;9(6):411–8. - PubMed
    1. Colantonio D, Kyriakopoulou L, Chan M, Daly C, Brinc D, Venner A, et al. Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children. Clin Chem. 2012;58(5):854–68. - PubMed
    1. Molleston JP, Schwimmer JB, Yates KP, Murray KF, Cummings OW, Lavine JE, et al. Histological abnormalities in children with nonalcoholic fatty liver disease and normal or mildly elevated alanine aminotransferase levels. J Pediatr. 2014;164(4):707–13 e3. - PMC - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources